The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude [Poster]
| Author: | C. Schneider, M. Wallner, M. Abdellatif, D. von Lewinski, Martin PichlerGND, S. Sedej, P. Rainer |
|---|---|
| Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/102854 |
| ISSN: | 1613-7671OPAC |
| Parent Title (German): | Wiener klinische Wochenschrift |
| Publisher: | Springer |
| Place of publication: | Wien |
| Type: | Article |
| Language: | English |
| Year of first Publication: | 2016 |
| Release Date: | 2023/03/31 |
| Volume: | 128 |
| Issue: | Suppl. 3 |
| First Page: | S109 |
| Last Page: | S110 |
| DOI: | https://doi.org/10.1007/s00508-016-1013-x |
| Institutes: | Medizinische Fakultät |
| Medizinische Fakultät / Universitätsklinikum | |
| Medizinische Fakultät / Professur für Translationale Krebsforschung |
